Research Article
Prevalence of Hepatitis B Carrier Status and Its Negative Association with Hypertensive Disorders in Pregnancy
Table 3
Incidence of hypertensive complications in pregnancy.
| | Total (n = 87889) | | 2000–2004 (n = 19523) | | 2005–2009 (n = 24261) | | 2010–2014 (n = 24343) | | 2015–2019 (n = 19763) | | HBV −ve (n = 79487) | HBV +ve (n = 8402) (9.56%) | value | HBV −ve (n = 17527) | HBV +ve (n = 1996) (10.2%) | value | HBV −ve (n = 21583) | HBV +ve (n = 2678) (11.05%) | value | HBV −ve (n = 21966) | HBV +ve (n = 2377) (9.7%) | value | HBV −ve (n = 18411) | HBV +ve (n = 1351) (6.8%) | value |
| Gestational hypertensiona | 2366 (2.97%) | 185 (2.20%) | <0.001 | 524 (2.98%) | 34 (1.70%) | <0.01 | 607 (2.81%) | 57 (2.12%) | 0.041 | 683 (3.11%) | 63 (2.65%) | 0.21 | 552 (2.99%) | 31 (2.29%) | 0.14 | PET without chronic HTb | 1103 (1.25%) | 66 (0.78%) | <0.001 | 195 (1.11%) | 12 (0.60%) | 0.047 | 282 (1.30%) | 19 (0.71%) | 0.043 | 319 (1.45%) | 23 (0.97%) | 0.07 | 307 (1.67%) | 12 (0.89%) | 0.038 | Chronic HT | 168 (0.21%) | 19 (0.22%) | 0.87 | 13 (0.07%) | 1 (0.05%) | 0.94 | 34 (0.15%) | 4 (0.15%) | 0.87 | 54 (0.24%) | 6 (0.25%) | 0.85 | 67 (0.36%) | 8 (0.59%) | 0.27 | PET superimposed on chronic HTc | 60 (0.07%) | 4 (0.04%) | 0.24 | 9 (0.05%) | 0 | — | 17 (0.08%) | 3 (0.11%) | 0.76 | 14 (0.06%) | 0 | — | 20 (0.11%) | 1 (0.07%) | 0.95 | Eclampsiad | 37 (0.04%) | 5 (0.06%) | 0.68 | 12 (0.07%) | 2 (0.1%) | 0.94 | 12 (0.06%) | 3 (0.11%) | 0.95 | 8 (0.03%) | 0 | — | 5 (0.03%) | 0 | — | All PET(e=b+c+d) | 1200 (1.50%) | 75 (0.89%) | <0.001 | 216 (1.23%) | 14 (0.70%) | 0.037 | 311 (1.44%) | 25 (0.93%) | 0.034 | 341 (1.55%) | 23 (0.97%) | 0.016 | 332 (1.80%) | 13 (0.96%) | 0.023 | Total hypertensive disorders(a+e) | 3566 (4.48%) | 260 (3.09%) | <0.001 | 740 (4.22%) | 48 (2.40%) | <0.001 | 918 (4.25%) | 82 (3.06%) | 0.001 | 1024 (4.66%) | 86 (3.62%) | 0.02 | 884 (4.80%) | 44 (3.26%) | 0.01 |
|
|
PET = preeclampsia, HT = hypertension.
|